GLYXAMBI EMPAGLIFLOZIN+LINAGLIPTIN 25/5MG

Glyxambi Empagliflozin + Linagliptin 25/5 mg Tablets – Advanced Dual Therapy for Type 2 Diabetes

Glyxambi 25/5 mg is a prescription medication designed to help manage blood sugar levels in adults with type 2 diabetes. It combines empagliflozin (25 mg), an SGLT2 inhibitor, and linagliptin (5 mg), a DPP-4 inhibitor, to provide complementary mechanisms for better glycemic control.

Empagliflozin is the active ingredient found in Jardiance, and linagliptin is the same as in Tradjenta.

💊 What Is It Used For?

Glyxambi 25/5 mg may be prescribed to:

• Improve blood sugar control in adults with type 2 diabetes

• Reduce HbA1c levels

• Support weight management as part of diabetes care

• Complement diet and exercise plans for better glucose control

Not intended for type 1 diabetes or diabetic ketoacidosis.

🔬 How It Works

This dual-action formula combines:

• Empagliflozin (SGLT2 inhibitor): Helps remove excess glucose through the urine, lowering blood sugar levels.

• Linagliptin (DPP-4 inhibitor): Increases incretin hormones to regulate insulin release and decrease glucose production after meals.

Together, they provide a balanced and effective approach to blood sugar management.

📦 Product Details

• Product Name: Glyxambi

• Strength: 25 mg Empagliflozin / 5 mg Linagliptin

• Form: Oral tablets

• Category: Prescription antidiabetic combination medication

• Indication: Type 2 diabetes management

⚠️ Important Safety Information

• Prescription only – use under medical supervision

• Inform your healthcare provider of kidney, liver, or heart conditions

• Stay hydrated to reduce the risk of dehydration

• Regular blood sugar and kidney function monitoring is recommended

Take control of your type 2 diabetes with Glyxambi 25/5 mg — effective dual therapy for better blood sugar balance and long-term health.

Disclaimer: This medication requires a valid prescription. Always consult your healthcare provider before starting or adjusting treatment.